| Literature DB >> 33994788 |
Liheng Chen1, Jiawei Sun2,3, Qiaohong Wang1, Lingzhen Hu1, Yi Zhang1, Huibin Ma2,3, Xize Jia4,5, Xuyan Yang1.
Abstract
PURPOSE: In this study, we seek to investigate dynamic changes of brain activity in non-neuropsychiatric systemic lupus erythematosus (non-NPSLE) patients with inactive disease. PATIENTS AND METHODS: Thirty-one non-NPSLE patients with inactive disease and 20 matched healthy controls underwent the blood oxygenation level-dependent fMRI examination. Dynamic regional homogeneity (ReHo) and fractional amplitude of low-frequency fluctuations (fALFF) were used to analyze the brain activity in typical band (0.01-0.08 Hz), slow-4 (0.027-0.073 Hz) and slow-5 (0.01-0.027 Hz). Pearson's correlation analysis was performed to correlate dynamic regional homogeneity (dReHo) and dynamic fractional amplitude of low-frequency fluctuations (dfALFF) values for clusters of voxels where significant group differences were found with clinical variables in non-NPSLE patients with inactive disease.Entities:
Keywords: dynamic fractional amplitude of low-frequency fluctuations; dynamic regional homogeneity; frequency bands; non-neuropsychiatric systemic lupus erythematosus; resting-state functional magnetic resonance imaging; systemic lupus erythematosus
Year: 2021 PMID: 33994788 PMCID: PMC8113012 DOI: 10.2147/NDT.S292302
Source DB: PubMed Journal: Neuropsychiatr Dis Treat ISSN: 1176-6328 Impact factor: 2.570
Demographic and Clinical Information in Patients and Healthy Controls
| Demographics | Non-NPSLE | HCs | |
|---|---|---|---|
| Age (years) | 35.54±7.38 | 34.60±8.25 | 0.682 |
| Education (years) | 12.21±3.61 | 13.60±3.97 | 0.215 |
| Disease duration (years) | 7.71±5.58 | N/A | N/A |
| SLEDAI | 1.25±1.17 | N/A | N/A |
| Antiphospholipid antibodies | 0 | N/A | N/A |
| Treatments | — | — | |
| Glucocorticoid (mg) | 7.48±4.88 | N/A | N/A |
| Hydroxychloroquine | 20 (71.4%) | N/A | N/A |
| Mycophenolate mofetil | 2 (0.07%) | N/A | N/A |
| Cyclophosphamide | 2 (0.07%) | N/A | N/A |
| C3 (g/L) | 0.70±0.20 | N/A | N/A |
| C4 (mg/L) | 119.68±65.23 | N/A | N/A |
| MMSE | 28.86±1.35 | 29.20±0.70 | 0.258 |
| FSS | 39.57±9.74 | 26.30±10.96 | <0.001 |
| BDI-II | 7.11±4.17 | 5.85±4.00 | 0.300 |
Notes: Thirty-one non-NPSLE patients and 20 healthy controls were enrolled in this study, three patients were excluded for further study for head motion over 3.0 mm of translation or 3.0° of rotation; p-value was obtained by the two-sample t-test, values are mean SD.
Abbreviations: Non-NPSLE, non-neuropsychiatric systemic lupus erythematosus; HCs healthy controls; SLEDAI, systemic lupus erythematosus disease activity index; MMSE, the Mini-mental state examination; FSS, fatigue severity scale; BDI-II, Beck Depression Inventory II scale.
The Difference in dReHo Value in Brain Regions between SLE and HCs
| Brain Regions | Cluster Size (Number of Voxels) | Peak MNI Coordinates | Peak Intensity | ||
|---|---|---|---|---|---|
| X | Y | Z | |||
| Typical band (0.01–0.08 Hz) | |||||
| Left MOG | 212 | −33 | −72 | 12 | 4.51 |
| Slow-4 (0.027–0.073 Hz) | |||||
| Left MOG | 102 | −33 | −72 | 0 | 4.05 |
| Slow-5 (0.01–0.027 Hz) | |||||
| Left CAL | 220 | −15 | −60 | 3 | 4.33 |
| Left MOG | 109 | −30 | −81 | 15 | 4.52 |
| Right PreCG | 152 | 45 | −18 | 48 | 4.99 |
| Left PoCG | 241 | −48 | −18 | 51 | 4.45 |
Abbreviations: MNI, Montreal Neurological Institute; MOG, middle occipital gyrus; CAL, calcarine fissure and surrounding cortex; PreCG, precentral gyrus; PoCG, postcentral gyrus.
Figure 1dReHo map of non-NPSLE patients versus healthy controls in different frequency bands. T-statistic dReHo maps of non-NPSLE patients versus healthy controls (HCs) (voxel p<0.005, cluster p<0.05, GRF corrected). (A) dReHo map of non-NPSLE patients versus healthy controls in typical band; (B) dReHo map of non-NPSLE patients versus healthy controls in slow-4; (C) dReHo map of non-NPSLE patients versus healthy controls in slow-5. Hot colors indicate increased dReHo in patients compared with HCs; cold colors indicate decreased dReHo in patients compared with HCs.
The Difference in dfALFF Value in Brain Regions between SLE and HCs
| Brain Regions | Cluster Size (Number of Voxels) | Peak MNI Coordinates | Peak Intensity | ||
|---|---|---|---|---|---|
| X | Y | Z | |||
| Typical band (0.01–0.08 Hz) | |||||
| Right MFG | 129 | 51 | 36 | 27 | −4.26 |
| Left MFG | 213 | −24 | 18 | 60 | −4.62 |
| Right SFG | 113 | 27 | −6 | 72 | −3.80 |
| Slow-4 (0.027–0.073 Hz) | |||||
| No significant brain regions | |||||
| Slow-5 (0.01–0.027 Hz) | |||||
| Left SFG | 155 | −24 | 15 | 66 | −4.51 |
| Right MFG | 82 | 39 | 27 | 48 | −4.65 |
| Right PreCG | 136 | 27 | −9 | 72 | −4.94 |
Abbreviations: MNI, Montreal Neurological Institute; MFG, middle frontal gyrus; SFG, superior frontal gyrus; PreCG, precentral gyrus.
Figure 2dfALFF map of non-NPSLE patients versus healthy controls in different frequency bands T-statistic dfALFF maps of non-NPSLE patients versus healthy controls (HCs) (voxel p<0.005, cluster p<0.05, GRF corrected). (A) dfALFF map of non-NPSLE patients versus healthy controls in typical band; (B) dfALFF map of non-NPSLE patients versus healthy controls in slow-5. Hot colors indicate increased dfALFF in patients compared with HCs; cold colors indicate decreased dfALFF in patients compared with HCs.
Figure 3Correlation analysis. The correlation analysis showed significantly negative correlations between the glucocorticoid dose and dReHo values in right PreCG in slow-5 (B), dReHo values in left PoCG in slow-5 (A), and dReHo values in left MOG in typical band (C).